We are live on ! Find out more
GNMK

GenMark Diagnostics, Inc
GNMK

Delisted

GNMK was delisted on the 21st of April, 2021.

Back to rankings

110 hedge funds and large institutions have $320M invested in GenMark Diagnostics, Inc in 2019 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 43 increasing their positions, 25 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

72% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 25

42% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 12

4% more funds holding

Funds holding: 106 → 110 (+4)

6% less capital invested

Capital invested by funds: $339M → $320M (-$19.3M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $46K

Holders
110
Holders Change
+4
Holders Change %
+3.77%
% of All Funds
2.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
17
Increased
43
Reduced
25
Closed
12
Calls
–
Puts
$46K
Net Calls
-$46K
Net Calls Change
+$3K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$14.2M
2
BlackRock
BlackRock
New York
+$2.65M
3
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D
New Jersey
+$2.23M
4
EIM
Essex Investment Management
Massachusetts
+$1.79M
5
QI
QS Investors
New York
+$1.7M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$22.4M
2
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$2.45M
3
HighTower Advisors
HighTower Advisors
Illinois
-$1.67M
4
JP Morgan Chase
JP Morgan Chase
New York
-$1.66M
5
Federated Hermes
Federated Hermes
Pennsylvania
-$1.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$52.2M +$385K +61,617 +0.7%
CCM
2
Cadian Capital Management
New York
$34.2M +$14.8K +2,370 +0%
BlackRock
3
BlackRock
New York
$25.7M +$2.65M +424,702 +11%
Morgan Stanley
4
Morgan Stanley
New York
$24.9M +$14.2M +2,280,101 +125%
CC
5
Casdin Capital
New York
$20.4M – – –
T. Rowe Price Associates
6
T. Rowe Price Associates
Maryland
$18.2M -$22.4M -3,589,340 -54%
Vanguard Group
7
Vanguard Group
Pennsylvania
$16.9M +$550K +88,110 +3%
HighTower Advisors
8
HighTower Advisors
Illinois
$14.2M -$1.67M -267,208 -10%
BG
9
Bellevue Group
Switzerland
$13.7M -$536K -85,815 -4%
Bank of America
10
Bank of America
North Carolina
$10.1M +$977K +156,533 +10%
State Street
11
State Street
Massachusetts
$6.69M +$284K +45,566 +4%
JP Morgan Chase
12
JP Morgan Chase
New York
$6.07M -$1.66M -265,453 -21%
Northern Trust
13
Northern Trust
Illinois
$4.59M +$508K +81,376 +12%
Geode Capital Management
14
Geode Capital Management
Massachusetts
$4.49M +$119K +19,129 +3%
PCM
15
Penn Capital Management
Pennsylvania
$3.88M +$16.2K +2,598 +0.4%
Renaissance Technologies
16
Renaissance Technologies
New York
$3.37M +$1.35M +216,400 +64%
Alyeska Investment Group
17
Alyeska Investment Group
Illinois
$3.32M +$468K +75,000 +16%
Goldman Sachs
18
Goldman Sachs
New York
$3.31M +$481K +77,071 +16%
N
19
Nuveen
North Carolina
$2.91M +$403K +64,636 +16%
Millennium Management
20
Millennium Management
New York
$2.71M -$621K -99,542 -18%
GIP
21
Granite Investment Partners
California
$2.54M +$701K +112,393 +37%
Thrivent Financial for Lutherans
22
Thrivent Financial for Lutherans
Minnesota
$2.49M -$353K -56,635 -12%
D.E. Shaw & Co
23
D.E. Shaw & Co
New York
$2.32M +$658K +105,373 +38%
Citadel Advisors
24
Citadel Advisors
Florida
$2.24M +$533K +85,450 +30%
State of New Jersey Common Pension Fund D
25
State of New Jersey Common Pension Fund D
New Jersey
$2.17M +$2.23M +357,300 New
1
2 3 4 5

GNMK Hedge Fund Activity: Q3 2019 in Review

110 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in GenMark Diagnostics, Inc (GNMK) for Q3 2019, worth a combined $320M — down 5.7% from $339M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new GNMK positions and 12 closed out — a net gain of 5 holders — while 43 added to existing stakes and 25 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $14.2M. The largest seller was T. Rowe Price Associates, cutting an estimated $22.4M.

  • 110 institutional investors held GenMark Diagnostics, Inc (GNMK) as of Q3 2019, up from 106 in Q2 2019.
  • Funds reported $320M of GenMark Diagnostics, Inc stock for Q3 2019, down 5.7% quarter-over-quarter.
  • 17 funds opened new GenMark Diagnostics, Inc positions in Q3 2019 and 12 closed out, a net change of +5 holders.
  • The largest GenMark Diagnostics, Inc buyer in Q3 2019 was Morgan Stanley, an estimated $14.2M added.
  • The largest GenMark Diagnostics, Inc seller in Q3 2019 was T. Rowe Price Associates, an estimated $22.4M sold.

Based on aggregated 13F filings for Q3 2019.